Equity
AOCI
ResMed AOCI increased by 16.6% to -$24.91M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 90.1%, from -$250.86M to -$24.91M. Over 4 years (FY 2021 to FY 2025), AOCI shows an upward trend with a -21.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
Fluctuations often signal changes in foreign exchange rates, interest rate environments, or pension funding status.
Detailed definition
Accumulated Other Comprehensive Income (AOCI) captures the cumulative unrealized gains and losses that are excluded from...
Peer comparison
Standard equity component for large multinational corporations with complex balance sheets.
Metric ID:
aociHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$193.49M | -$217.00M | -$223.10M | -$224.14M | -$312.75M | -$406.13M | -$270.17M | -$261.88M | -$272.53M | -$320.15M | -$208.35M | -$265.31M | -$251.53M | -$132.16M | -$298.89M | -$250.86M | -$74.70M | -$60.72M | -$29.86M | -$24.91M |
| QoQ Change | — | -12.2% | -2.8% | -0.5% | -39.5% | -29.9% | +33.5% | +3.1% | -4.1% | -17.5% | +34.9% | -27.3% | +5.2% | +47.5% | -126.2% | +16.1% | +70.2% | +18.7% | +50.8% | +16.6% |
| YoY Change | — | — | — | — | -61.6% | -87.2% | -21.1% | -16.8% | +12.9% | +21.2% | +22.9% | -1.3% | +7.7% | +58.7% | -43.5% | +5.4% | +70.3% | +54.1% | +90.0% | +90.1% |
Range-$406.13M – -$24.91M
CAGR-35.1%
Avg YoY Growth+12.6%
Median YoY Growth+10.3%
Current Streak5 quarters growth
AOCI at Other Companies
Frequently Asked Questions
- What is ResMed's aoci?
- ResMed (RMD) reported aoci of -$24.91M in Q1 2026.
- How has ResMed's aoci changed year-over-year?
- ResMed's aoci increased by 90.1% year-over-year, from -$250.86M to -$24.91M.
- What is the long-term trend for ResMed's aoci?
- Over 4 years (2021 to 2025), ResMed's aoci has grown at a -21.2% compound annual growth rate (CAGR), from -$193.49M to -$74.70M.
- What does aoci mean?
- The cumulative total of unrealized gains and losses not yet reflected in net income.